TELOMERE LOSS IN PH - NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS: THE ROLE OF JAK2 V617F MUTATION ALLELE BURDEN AND THE INFLUENCE OF THE HISTORY OF THE ILLNESS

被引:0
|
作者
Ruella, M. [1 ]
Salmoiraghi, S. [2 ]
Risso, A.
Carobbio, A. [2 ]
Sivera, P. [3 ]
Mezzabotta, M. [3 ]
Ricca, I. [4 ]
Barbui, T. [2 ]
Tarella, C. [3 ]
Rambaldi, A. [2 ]
机构
[1] Univ Turin, Turin, Italy
[2] Ospedali Riuniti Bergamo, Bergamo, Italy
[3] ASO Mauriziano, Turin, Italy
[4] AO Cottolengo, Turin, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0403
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [31] Diagnostic assays for the JAK2 V617F mutation in chronic myeloproliferative disorders
    Greiner, TC
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (05) : 651 - 653
  • [32] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Yoko Edahiro
    Soji Morishita
    Kochi Takahashi
    Yumi Hironaka
    Yuriko Yahata
    Yoshitaka Sunami
    Shuichi Shirane
    Miyuki Tsutsui
    Masaaki Noguchi
    Michiaki Koike
    Kiyotoshi Imai
    Keita Kirito
    Naohiro Noda
    Yuji Sekiguchi
    Satoshi Tsuneda
    Akimichi Ohsaka
    Marito Araki
    Norio Komatsu
    International Journal of Hematology, 2014, 99 : 625 - 634
  • [33] JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan
    Edahiro, Yoko
    Morishita, Soji
    Takahashi, Kochi
    Hironaka, Yumi
    Yahata, Yuriko
    Sunami, Yoshitaka
    Shirane, Shuichi
    Tsutsui, Miyuki
    Noguchi, Masaaki
    Koike, Michiaki
    Imai, Kiyotoshi
    Kirito, Keita
    Noda, Naohiro
    Sekiguchi, Yuji
    Tsuneda, Satoshi
    Ohsaka, Akimichi
    Araki, Marito
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 625 - 634
  • [34] Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms
    Benati, Marco
    Montagnana, Martina
    Danese, Elisa
    De Matteis, Giovanna
    Veneri, Dino
    Paviati, Elisa
    Guidi, Gian Cesare
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (07) : 1005 - 1011
  • [35] The JAK2 V617F mutational status and allele burden
    Liang, Shanshan
    Zhou, Yanhong
    THROMBOSIS RESEARCH, 2015, 136 (03) : 690 - 690
  • [36] Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
    Kim, Hye-Ran
    Choi, Hyun-Jung
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Shin, Jong-Hee
    Suh, Soon-Pal
    Ryang, Dong-Wook
    Shin, Myung-Geun
    PLOS ONE, 2013, 8 (01):
  • [37] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
    Choi, Daniel C.
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Messali, Nassima
    Yabut, Maria Mia
    Erdos, Katie
    Scandura, Joseph M.
    BLOOD, 2023, 142
  • [38] Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR
    Waterhouse, Miguel
    Follo, Marie
    Pfeifer, Dietmar
    von Bubnoff, Nikolas
    Duyster, Justus
    Bertz, Hartmut
    Finke, Juergen
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 739 - 744
  • [39] Sensitive and accurate quantification of JAK2 V617F mutation in chronic myeloproliferative neoplasms by droplet digital PCR
    Miguel Waterhouse
    Marie Follo
    Dietmar Pfeifer
    Nikolas von Bubnoff
    Justus Duyster
    Hartmut Bertz
    Jürgen Finke
    Annals of Hematology, 2016, 95 : 739 - 744
  • [40] The clinical value of plasma CFDNA JAK2 V617F mutation detection in myeloproliferative neoplasms
    Wu, Q.
    Cao, G.
    Guan, M.
    CLINICA CHIMICA ACTA, 2024, 558